(Total Views: 553)
Posted On: 05/25/2020 5:33:56 PM
Post# of 154009
HEALTH
Bay Area search for coronavirus drugs extends far beyond remdesivir
Photo of J.D. Morris
J.D. Morris
May 25, 2020 Updated: May 25, 2020 5 a.m.
Comments
CEO Bruce Patterson of IncellDx in the company's laboratory in San Carlos, Calif., on Monday, May 11, 2020. Patterson, who is doing lab work for drug company CytoDyn, says he's uncovered an important aspect of how coronavirus functions and found evidence that the virus may be infectious in the blood.
CEO Bruce Patterson of IncellDx in the company's laboratory in San Carlos, Calif., on Monday, May 11, 2020. Patterson, who is doing lab work for drug company CytoDyn, says he's uncovered an important aspect of how coronavirus functions and found evidence that the virus may be infectious in the blood.
Photo: Scott Strazzante / The Chronicle
Remdesivir, the antiviral drug made by Foster City’s Gilead Sciences that has recently shown promise in treating COVID-19 patients, will likely not turn the tide of the coronavirus pandemic on its own.
Doctors in the Bay Area know that, which is why they’re studying a host of other potential treatments that could be used to alleviate the worst symptoms of COVID-19 or keep people out of the hospital entirely. And the scope of the local research seems to be broadening.
Bay Area search for coronavirus drugs extends far beyond remdesivir
Photo of J.D. Morris
J.D. Morris
May 25, 2020 Updated: May 25, 2020 5 a.m.
Comments
CEO Bruce Patterson of IncellDx in the company's laboratory in San Carlos, Calif., on Monday, May 11, 2020. Patterson, who is doing lab work for drug company CytoDyn, says he's uncovered an important aspect of how coronavirus functions and found evidence that the virus may be infectious in the blood.
CEO Bruce Patterson of IncellDx in the company's laboratory in San Carlos, Calif., on Monday, May 11, 2020. Patterson, who is doing lab work for drug company CytoDyn, says he's uncovered an important aspect of how coronavirus functions and found evidence that the virus may be infectious in the blood.
Photo: Scott Strazzante / The Chronicle
Remdesivir, the antiviral drug made by Foster City’s Gilead Sciences that has recently shown promise in treating COVID-19 patients, will likely not turn the tide of the coronavirus pandemic on its own.
Doctors in the Bay Area know that, which is why they’re studying a host of other potential treatments that could be used to alleviate the worst symptoms of COVID-19 or keep people out of the hospital entirely. And the scope of the local research seems to be broadening.
(0)
(0)
